Total Funding
51
51
Total FundingGrant raised
Growth Score
-10 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
110047
Bexion Pharmaceuticals is a privately-held biotech company focused on the development and commercialization of innovative cures for cancer.
Past Role: Solana Company, Chief Financial Officer and Chief Operations Officer.- R. Scott Shively: President & CEO ,Board Of DirectorPast Role: Neumentum, CEO & Co-Founder
About the Company
Bexion Pharmaceuticals is developing innovative cures for cancer. Unlike any other potential drug known in development, BXQ-350 has an entirely new and novel mechanism of action. Studies strongly suggest that specific tumor targeting is the result of targeting Phosphatidylserine patches that are characteristic of tumor cells and neovasculature; and
that apoptosis results from activation of acid sphingomyelinase, subsequent generation of ceramide, and elevated levels of caspase.
